Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1961 1
1962 1
1964 1
1965 1
1966 1
1968 2
1969 4
1970 2
1971 4
1973 4
1974 3
1975 6
1976 6
1977 14
1978 12
1979 6
1980 15
1981 8
1982 17
1983 10
1984 19
1985 19
1986 21
1987 13
1988 23
1989 16
1990 20
1991 15
1992 17
1993 14
1994 9
1995 20
1996 11
1997 31
1998 30
1999 20
2000 27
2001 25
2002 25
2003 21
2004 22
2005 28
2006 20
2007 21
2008 32
2009 41
2010 41
2011 30
2012 47
2013 36
2014 32
2015 43
2016 54
2017 51
2018 56
2019 50
2020 67
2021 71
2022 73
2023 73
2024 63
2025 77
2026 70

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,457 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab on Remission Induction in ANCA-Associated Vasculitis: A Randomized Clinical Trial.
Furuta S, Nakagomi D, Kobayashi Y, Hiraguri M, Sugiyama T, Amano K, Umibe T, Kono H, Kurasawa K, Kita Y, Matsumura R, Kaneko Y, Ninagawa K, Hiromura K, Kagami SI, Inaba Y, Hanaoka H, Ikeda K, Nakajima H; LoVAS Collaborators. Furuta S, et al. Among authors: amano k. JAMA. 2021 Jun 1;325(21):2178-2187. doi: 10.1001/jama.2021.6615. JAMA. 2021. PMID: 34061144 Free PMC article. Clinical Trial.
A prospective, multicenter, open-label phase III study of emicizumab prophylaxis in patients with acquired hemophilia A.
Shima M, Amano K, Ogawa Y, Yoneyama K, Ozaki R, Kobayashi R, Sakaida E, Saito M, Okamura T, Ito T, Hattori N, Higasa S, Suzuki N, Seki Y, Nogami K. Shima M, et al. Among authors: amano k. J Thromb Haemost. 2023 Mar;21(3):534-545. doi: 10.1016/j.jtha.2022.10.004. Epub 2022 Dec 22. J Thromb Haemost. 2023. PMID: 36696195 Free article. Clinical Trial.
[Overview].
Amano K. Amano K. Rinsho Ketsueki. 2021;62(5):429. doi: 10.11406/rinketsu.62.429. Rinsho Ketsueki. 2021. PMID: 34108325 Japanese. No abstract available.
Final Analysis Results from the AGEHA Study: Emicizumab Prophylaxis for Acquired Hemophilia A with or without Immunosuppressive Therapy.
Shima M, Suzuki N, Nishikii H, Amano K, Ogawa Y, Kobayashi R, Ozaki R, Yoneyama K, Mizuno N, Sakaida E, Saito M, Okamura T, Ito T, Hattori N, Higasa S, Seki Y, Nogami K. Shima M, et al. Among authors: amano k. Thromb Haemost. 2025 May;125(5):449-459. doi: 10.1055/a-2384-3585. Epub 2024 Aug 12. Thromb Haemost. 2025. PMID: 39134043 Free PMC article. Clinical Trial.
Reduced-dose versus high-dose glucocorticoids added to rituximab on remission induction in ANCA-associated vasculitis: predefined 2-year follow-up study.
Furuta S, Nakagomi D, Kobayashi Y, Hiraguri M, Sugiyama T, Amano K, Umibe T, Kono H, Kurasawa K, Kita Y, Matsumura R, Kaneko Y, Ninagawa K, Hiromura K, Kagami SI, Inaba Y, Hanaoka H, Ikeda K, Nakajima H; LoVAS collaborators. Furuta S, et al. Among authors: amano k. Ann Rheum Dis. 2024 Jan 2;83(1):96-102. doi: 10.1136/ard-2023-224343. Ann Rheum Dis. 2024. PMID: 37734880 Clinical Trial.
[Acquired hemophilia A].
Amano K. Amano K. Rinsho Ketsueki. 2018;59(6):756-763. doi: 10.11406/rinketsu.59.756. Rinsho Ketsueki. 2018. PMID: 29973457 Review. Japanese.
Comparison of genotypes and phenotypes for von Willebrand factor gene variants using Japanese genome database.
Akimoto T, Inaba H, Ogishima S, Kumada K, Mitsuhashi A, Miyashita R, Yamaguchi T, Bingo M, Chikasawa Y, Shinozawa K, Hagiwara T, Amano K, Kodama EN, Kinai E. Akimoto T, et al. Among authors: amano k. Blood Vessel Thromb Hemost. 2025 Apr 10;2(3):100070. doi: 10.1016/j.bvth.2025.100070. eCollection 2025 Aug. Blood Vessel Thromb Hemost. 2025. PMID: 40765908 Free PMC article.
Pediatric Optic Pathway/Hypothalamic Glioma.
Aihara Y, Chiba K, Eguchi S, Amano K, Kawamata T. Aihara Y, et al. Among authors: amano k. Neurol Med Chir (Tokyo). 2018 Jan 15;58(1):1-9. doi: 10.2176/nmc.ra.2017-0081. Epub 2017 Nov 9. Neurol Med Chir (Tokyo). 2018. PMID: 29118304 Free PMC article. Review.
1,457 results